Gamze MUZ, Ayser ERAT, Şeydanur ŞAMDANLI, Nisa YAVUZER

Kronik obstrüktif akciğer hastalığı tanısı almış bireylerin integratif yöntemleri kullanma durumu ve umutsuzluk düzeyleri ile ilişkisi

Amaç: Kronik hastalıkların artması semptom yönetiminde integratif yöntemlerin kullanımını önemli ölçüde arttırmaktadır. Bu çalışma, Kronik Obstrüktif Akciğer Hastalığı (KOAH) olan bireylerin integratif uygulamaları kullanımını ve umutsuzluk düzeylerini belirlemeyi amaçlamaktadır. Gereç ve Yöntem: Kesitsel ve tanımlayıcı nitelikteki bu çalışma, bir devlet hastanesinin göğüs hastalıkları hizmetlerinde yürütülmüştür. Veriler Anket Formu ve Beck’in Umutsuzluk Ölçeği ile toplanmıştır. Bulgular: Katılımcıların %29,7'sinin integratif uygulamaları kullandığı, en sık görülen integratif uygulamaların bitkisel yöntemler olduğu (%66,2) saptandı. İntegratif uygulamaları kullanan grubun umutsuzluk düzeyi yüksekti, ancak gruplar arasındaki fark istatistiksel olarak anlamlı değildi. Katılımcılar integratif uygulamaların kullanımı ile ilgili bilgiyi TV, radyo ve magazinden aldığı ve intagratif uygulamları en fazla semptom yönetiminde kullandıkları belirlenmiştir. Sonuç: En sık görülen integratif uygulamalar bitkisel yöntemlerin olduğu, ayrıca umutsuzluk düzeyinin integratif uygulama kullanımını etkilemediği belirlenmiştir. Bu bulguların sonuçları doğrultusunda, integratif uygulama nedenlerini tanımlamak ve sağlık profesyonellerinin bu alanda hastalara eğitim vermesi önerilebilir.

Use of integrative medicines by chronic obstructive pulmonary disease patients and its relation with hopelessness levels

Purpose: Increase in chronic diseases significantly increases the use of integrative medicines in symptom management. This study aims to determine the use of integrative medicines and the levels of hopelessness of individuals with chronic obstructive pulmonary disease (COPD). Material and Methods: This descriptive and cross-sectional study was conducted in a chest disease services with 259 COPD’s patients. Data were collected with the Questionnaire Form and Beck’s Hopelessness Scale. Results: Of the participants, the most common integrative medicine was herbal methods (66.2%). The hopelessness level of the group using integrative medicine was high, but the difference between the groups was not statistically significant. The participants received information about the use of integrative methods from TV, radio and magazine and used integrative methods in symptom management. Conclusion: The most common integrative medicine used was herbal methods. In addition, level of hopelessness did not affect integrative medicine’s usage. The results of such findings are to identify the causes of integrative medicine use and to ensure education for healthcare professionals.

Keywords:

complemantary medicine, COPD, hope,

PDF

___

1. GOLD. Global Initiative for Chronic Obstructive Lung Disease. “Global Strategy for the Diagnosis, Management and Prevention. A Guide for Health Care Professionals 2019 Report.” 2019.
2. Chronic obstructive pulmonary disease (COPD). https://www.who.int/news-room/fact- sheets/detail/chronic-obstructive-pulmonary- disease-(copd) (accessed 2020 Jul 27).
3. Chronic obstructive pulmonary disease 2019. https://www.toraks.org.tr/halk/Page.aspx?d=10 (accessed 2020 Apr 16).
4. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2020. www.goldcopd.org
5. Minakata Y, Morishita Y, Ichikawa T, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K et al. Effects of pharmacologic treatment based on airflow limitation and breathlessness on daily physical activity in patients with chronic obstructive pulmonary disease. Int J COPD. 2015;10:1275-1282.
6. Ding B, Small M, Bergström G, Holmgren U. COPD symptom burden: Impact on health care resource utilization, and work and activity impairment. Int J COPD. 2017;12:677-89.
7. Polat H, Erguney S. The effect of reflexology applied to patients with chronic obstructive pulmonary disease on dyspnea and fatigue. Rehabil Nurs. 2017;42:14–21.
8. Oncu E, Zincir H. The effect of transcutaneous electrical nerve stimulation in patients with acute exacerbation of chronic obstructive pulmonary disease: randomised controlled trial. J Clin Nurs. 2017;26:1834-44.
9. Mularski RA, Munjas BA, Lorenz KA, Sun S, Robertson SJ, Schmelzer W et al. Randomized controlled trial of mindfulness-based therapy for dyspnea in chronic obstructive lung disease. J Altern Complement Med. 2009;15:1083–90.
10. Kütmeç Yılmaz C, Duru Aşiret G, Çetinkaya F, Kapucu S. The use of complementary and alternative medicine of chronic obstructive pulmonary disease patients. DEUHFED. 2017;10:216-21.
11. Yıldız Gülhan P, Güleç Balbay E, Üzer F. Evaluation of traditional and complementary medicine uses in chronic obstructive pulmonary patients. Online Turkish J Heal Sci. 2020;5:147-54.
12. Akinci AC, Zengin N, Yildiz H, Sener E, Gunaydin B. The complementary and alternative medicine use among asthma and chronic obstructive pulmonary disease patients in the southern region of Turkey. Int J Nurs Pract 2011;17:571–82.
13. WHO. Traditional Medicine Strategy 2002-2005. Geneva 2002. http://whqlipdoc.who.int/hq/2002/WHO_EDM_ TRM_2002.1.pdf.
14. Yuce GE, Tasci S. Effect of pranayama breathing technique on asthma control, pulmonary function, and quality of life: A single-blind, randomized, controlled trial. Complement Ther Clin Pract. 2020;38:101081.
15. Ceyhan O, Tasci S, Elmali F, Dogan A. The effect of acupressure on cardiac rhythm and heart rate among patients with atrial fibrillation: The relationship between heart rate and fatigue. Altern Ther Health Med. 2019;25:12–19.
16. Ozdemir U, Tasci S, Yildizhan E, Aslan S, Eser B. The Effect of classical Turkish music on pain severity and anxiety levels in patients undergoing bone marrow aspiration and biopsy. Pain Manag Nurs. 2019;20:82– 7.
17. Akca NK, Tasci S, Karatas N. Effect of acupressure on patients in Turkey receiving hemo dialysis treatment for uremic pruritus. Altern Ther Heal Med. 2013;19:12–18.
18. Muz G, Taşcı S. Effect of aromatherapy via inhalation on the sleep quality and fatigue level in people undergoing hemodialysis. Appl Nurs Res. 2017;37:28- 35.
19. Reel J, Campbell H, Kerr G, Sinclair M. Complementary therapies for chronic obstructive pulmonary disease. J Community Med Health Educ. 2016;6:125.
20. Sahin ZA, Sahin M. The view of patients with chronic obstructive pulmonary disease (COPD) on complementary and alternative medicine (CAM) in Eastern Turkey. African J Tradit Complement Altern Med. 2013;10:116–21.
21. Demir G, Akkoca Ö, Doğan R, Saryal S, Karabıyıkoğlu G. KOAH’da dispne ve yaşam kalitesinin değerlendirilmesi. Tüberküloz ve Toraks Derg. 2003;51:365-72.
22. Marciniuk DD, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: A Canadian Thoracic Society clinical practice guideline. Can Respir J. 2011;18:69– 78.
23. Kocabaş A, Atış S, Çöplü L, Erdinç E, Ergan B, Gürgün A et al. Kronik obstrüktif akciğer hastalığI (KOAH) koruma, tanı ve tedavi raporu 2014 Türk Toraks Derneği KOAH Çalışma Grubu. 2014. Turkish Thoracic Journal. 2015;15(Ek2):S1-72.
24. Negi H, Sarkar M, Raval A, Pandey K, Das P. Health- related quality of life in patients with chronic obstructive pulmonary disease in North India. J Postgrad Med 2014;60:7–11.
25. Güven Ş., Muz G, Ertürk N., Özcan A. Hipertansiyonlu bireylerde tamamlayıcı ve alternatif tedavi kullanma durumu. Balıkesir Sağlık Bilim Derg. 2016;2:160–6.
26. Özçelik H, Fadiloğlu Ç. Reasons for use of complementary and alternative medicine in cancer patients. Türk Onkol Derg. 2009;24:48–52.
27. Çakmak S, Nural N. Kronik hastalıklarda tamamlayıcı ve alternatif tedavi uygulamaları. J Intern Med Nurs- Special Top. 2017;3:57–64.
28. Emri S, Demir A, Dogan M, Akay H, Bozkurt B, Carbone M, Baris I. Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicol Lett. 2002;127:251–7.
29. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–191.
30. Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: The Hopelessness Scale. J Consult Clin Psychol. 1974;42:861–5.
31. Seber G, Dilbaz N, Kaptanoğlu C, Tekin D. Umutsuzluk ölçeği: geçerlilik ve güvenirliği. Kriz Dergisi. 1998;1:001–004.
32. Durak A, Palabiyikoğlu R. Beck umutsuzluk ölçeği geçerlilik çalışması. Kriz Dergisi.. 1994;2:311–19.
33. Gülhan Yıldız P, Üzer F, Balbay Güleç E. Astım tanılı hastalarda geleneksel ve tamamlayıcı tıp yöntemi kullanımlarının değerlendirilmesi. Bozok Med J. 2020;10:106–10.
34. Cevik AB, Akinci AC, Baglama SS. The use of complementary and alternative medicine among lymphoma and cancer patients with a solid tumor: Oncology clinics at Northern and Southern Turkey. Complement Ther Med 2019;47:102173.
35. Toygar İ, Yeşilbalkan ÖU, Kürkütlü M, Aslan A. Complementary and alternative medicines used by cancer patients to cope with chemotherapy-induced constipation. Complement Ther Clin Pract 2020;39:101108.
36. Sárváry A, Sárváry A. Use of complementary and alternative medicine among breast cancer patients in Hungary: A descriptive study. Complement Ther Clin Pract. 2019;35:195–200.
37. Erdoğan Z, Çınar S, Şimşek S. Hemodiyaliz hastalarında tamamlayıcı tıp yöntemlerini kullanma durumu ve umutsuzluk düzeyi ile ilişkisi. Spatula DD. 2013;3:107–112.
38. Şar Ş. Folk medicine practice in Anatolia. Turkiye Klin J Med Ethics. 2005;13:131–6.
39. Ince N, Kaya Ş, Esen Yıldız İ, Parlak E, Bayar B. Use of complementary and alternative medicine in patients with chronic viral hepatitis in Turkey. Complement Ther Med 2020;48:102229.
40. Abadoglu O, Cakmak E, Kuzucu Demir S. The view of patients with asthma or chronic obstructive pulmonary disease (COPD) on complementary and alternative medicine. Allergol Immunopathol (Madr). 2008;36:21–5.
41. Gürol A, Şener Taplak A, Polat S. Herbal supplement products used by mothers to cope with the common health problems in childhood. Complement Ther Med 2019;47:102214.
42. Irmak Z, Tanrıverdi Ö, Ödemiş H, Uysal DD. Use of complementary and alternative medicine and quality of life of cancer patients who received chemotherapy in Turkey. Complement Ther Med 2019;44:143–150.
43. Haifeng W, Hailong Z, Jiansheng L, Xueqing Y, Suyun L, Bin L et al.. Effectiveness and safety of traditional Chinese medicine on stable chronic obstructive pulmonary disease: A systematic review and meta-analysis. Complement Ther Med. 2015;23:603–11.
44. Tokem Y, Aytemur ZA, Yildirim Y, Fadiloglu C. Investigation into the use of complementary and alternative medicine and affecting factors in Turkish asthmatic patients. J Clin Nurs 2012;21:698–707.
45. Argüder E, Bavbek S, Şen E, Köse K, Keskin Ö, Saryal S et al. Is there any difference in the use of complementary and alternative therapies in patients asthma and COPD? A cross-sectional survey. J Asthma. 2009;46:252–8.
46. Liem KS, Yim C, Ying TD, Zanjir WR, Fung S, Wong DK et al. Prevalence and predictors of complementary and alternative medicine modalities in patients with chronic hepatitis B. Liver Int 2019;39:1418–27.
47. Cengiz Z, Budak F. Use of complementary medicine among people with diabetes in eastern Turkey: A descriptive study. Complement Ther Clin Pract 2019;36:120–4.
48. Di YM, Yang L, Shergis JL, Zhang AL, Li Y, Guo X, et al. Clinical evidence of Chinese medicine therapies for depression in women during perimenopause and menopause. Complement Ther Med. 2019;47:102071.
49. Malak AT, Karayurt Ö, Demir E, Yümer AS. Complementary and alternative medicine in cancer patients-analysis of influencing factors in Turkey. Asian Pacific J Cancer Prev. 2009;10:1083–88.
50. Gross AH, Cromwell J, Fonteyn M, Matulonis UA, Hayman LL. Hopelessness and complementary therapy use in patients with ovarian cancer. Cancer Nurs. 2013;36:256–64.